Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01401309 · ClinicalTrials.gov registry record
PET Respiratory Gating to Detect Hepatic Metastasis in Patients With Colon Cancer
A clinical trial, sponsored by Southwestern Regional Medical Center.
- Completed
- Registry status
- 81
- Enrollment target
NCT01401309: Completed study, sponsored by Southwestern Regional Medical Center.
NCT01401309 is a clinical trial that has completed, run by Southwestern Regional Medical Center. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01401309 has completed, sponsored by Southwestern Regional Medical Center.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
Study Summary
This study is to examine if there is improved sensitivity in detecting hepatic lesions using respiratory gating and if there is an improvement in confidence defining lesions as benign or malignant.
Primary Outcome
To exam if there is an improved sensitivity in detecting hepatic lesions using respiratory gating and if there is improvement in confidence defining lesions as benign or malignant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-03 |
What the finished NCT01401309 record still lists
NCT01401309 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01401309 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01401309 about?
NCT01401309 is a clinical study titled "PET Respiratory Gating to Detect Hepatic Metastasis in Patients With Colon Cancer". This study is to examine if there is improved sensitivity in detecting hepatic lesions using respiratory gating and if there is an improvement in confidence defining lesions as benign or malignant.
What is the current status of trial NCT01401309?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2011-01. Estimated completion is 2013-03.
Who is sponsoring clinical trial NCT01401309?
This trial is sponsored by Southwestern Regional Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia